ArticleGlobal epidemiology2026
Epidemiology and containment of the first Marburg virus disease outbreak in Ethiopia in 2025: A retrospective descriptive study.
Article in Global epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In November 2025, Ethiopia confirmed its first Marburg Virus Disease (MVD) outbreak in Jinka, marking a significant geographical expansion of the virus with a 64% case fatality rate. This study characterizes the transmission dynamics of the 2025 MVD outbreak in Ethiopia and evaluates the impact of the national public health containment strategy on the epidemic trajectory. Methods: We conducted a retrospective descriptive analysis using surveillance and laboratory data from November 14 to December 30, 2025. Transmission intensity was quantified using basic (R Findings: The outbreak involved 14 confirmed cases and 9 fatalities (CFR: 64%). The initial R Interpretation: The findings are consistent with the hypothesis that the combination of rapid diagnostic scaling decentralized incident management and technological integration were temporally associated with the truncation of MVD transmission chains. The integrated approach of decentralized management and rapid technological deployment offers a framework for viral hemorrhagic fever preparedness in similar resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.